STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 106 filers reported holding STOKE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $250,783 | -16.0% | 23,592 | -34.2% | 0.03% | -15.0% |
| Q1 2023 | $298,514 | -20.1% | 35,836 | -11.4% | 0.04% | -33.3% |
| Q4 2022 | $373,464 | +86.7% | 40,462 | +159.2% | 0.06% | +100.0% |
| Q3 2022 | $200,000 | -36.1% | 15,611 | -34.0% | 0.03% | +7.1% |
| Q2 2022 | $313,000 | -63.6% | 23,670 | -7.4% | 0.03% | -50.9% |
| Q2 2021 | $860,000 | +232.0% | 25,554 | +283.9% | 0.06% | +200.0% |
| Q1 2021 | $259,000 | – | 6,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |